Novartis AG (NVS)
99.57
+0.50
(+0.50%)
USD |
NYSE |
May 08, 16:00
99.57
0.00 (0.00%)
After-Hours: 20:00
Novartis Accounts Payable (Quarterly): 4.062B for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.062B |
December 31, 2023 | 4.926B |
September 30, 2023 | 3.87B |
June 30, 2023 | 5.35B |
March 31, 2023 | 5.426B |
December 31, 2022 | 5.146B |
September 30, 2022 | 4.693B |
June 30, 2022 | 4.969B |
March 31, 2022 | 5.083B |
December 31, 2021 | 5.553B |
September 30, 2021 | 4.665B |
June 30, 2021 | 4.811B |
March 31, 2021 | 5.04B |
December 31, 2020 | 5.403B |
September 30, 2020 | 4.705B |
June 30, 2020 | 4.82B |
March 31, 2020 | 4.828B |
December 31, 2019 | 5.424B |
September 30, 2019 | 4.669B |
June 30, 2019 | 4.752B |
March 31, 2019 | 4.638B |
December 31, 2018 | 5.556B |
September 30, 2018 | 4.97B |
June 30, 2018 | 5.486B |
March 31, 2018 | 4.994B |
Date | Value |
---|---|
December 31, 2017 | 5.169B |
September 30, 2017 | 4.685B |
June 30, 2017 | 4.691B |
March 31, 2017 | 4.566B |
December 31, 2016 | 4.873B |
September 30, 2016 | 4.662B |
June 30, 2016 | 4.92B |
March 31, 2016 | 4.704B |
December 31, 2015 | 5.668B |
September 30, 2015 | 4.825B |
June 30, 2015 | 5.126B |
March 31, 2015 | 5.062B |
December 31, 2014 | 5.419B |
September 30, 2014 | 4.52B |
June 30, 2014 | 4.991B |
March 31, 2014 | 5.485B |
December 31, 2013 | 6.148B |
September 30, 2013 | 5.079B |
June 30, 2013 | 5.042B |
March 31, 2013 | 4.875B |
December 31, 2012 | 5.593B |
September 30, 2012 | 4.591B |
June 30, 2012 | 4.585B |
March 31, 2012 | 4.487B |
December 31, 2011 | 4.989B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.87B
Minimum
Sep 2023
5.553B
Maximum
Dec 2021
4.910B
Average
4.877B
Median
Accounts Payable (Quarterly) Benchmarks
Roche Holding AG | 4.196B |
Sandoz Group AG | -- |
Amgen Inc | 1.628B |
Incyte Corp | 164.24M |
MorphoSys AG | 31.38M |